ARTICLE | Clinical News
ABS-103 valproic acid analog regulatory update
October 1, 2001 7:00 AM UTC
MABA received U.S. Patent No. 6,268,396 covering the use of the valproic acid analog 2-n-propyl-4-hexynoic acid to prevent and treat migraine and affective illness (unipolar or bipolar disorders and a...